David Dvorak has been appointed chairman of the board and CEO of Jintel Health. Ping Zhang, founder of Richmond, CA-based Jintel, will become president of the company. Dvorak is the former chief executive of medical devices giant Zimmer Biomet (NYSE: ZBH). Jintel says it has developed technology that uses analytics and machine learning for clinical and research applications.
Concurrent with the executive moves, Jintel announced that it completed a round of financing with Black Lake Expeditions as the sole investor. The amount raised from the investment was not disclosed.